Alex Birkenshaw

Senior Associate Scientist, Formulation

Focus at NanoVation TherapeuticsTM

Improving LNPs for base editing applications

Bio

I completed my BSc. at UBC where I first joined Colin Ross’s lab. My PhD focused on using LNPs to deliver gene editors with the goal of improving treatments for rare genetic disease. I started with NanoVation as a Mitacs student during my PhD before joining the formulation team.

Interests / hobbies

Hiking, making pottery, and hanging out with my cats Callie and
Lila